Comparaisons Financières Aclaris Therapeutics, Inc.
Actions
ACRS
US00461U1051
Recherche biotechnologique et médicale
|
Temps réel estimé
Cboe BZX
18:35:18 10/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 5,415 USD | -2,61% |
|
-8,82% | +80,23% |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Chiffre d'affaires (Y-1) | Marge nette (Y-1) | Marge EBIT (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | |
|---|---|---|---|---|---|---|---|
 | 7,83 M | -829,58% | -975,91% | - | - | - | |
| 6,5 Md | 42,13% | 52,64% | 28,56% | 20,88% | -0.99x | |
| 4,25 Md | 30,41% | 24,81% | 20,15% | 17,36% | -3.18x | |
| 606 M | -210,54% | -205,59% | -249,28% | - | 0.72x | |
| 3,12 Md | 22,53% | 31,44% | 11,9% | 8,13% | -1.19x | |
| 3,37 Md | -39,59% | -48,95% | -5,88% | -5,1% | 6.99x | |
| 3,69 Md | 25,89% | 28,63% | 17,53% | 9,99% | -1.51x | |
| 498 M | 32,27% | 31,52% | 16,97% | 14,74% | -3.83x | |
| 294 M | -18,56% | -24,05% | -9,34% | -9,05% | 8.22x | |
| 2,32 Md | 33,73% | 37,59% | 35,53% | 27,02% | -1.18x | |
| 958 M | -30,08% | -31,31% | -42,49% | - | 2.15x | |
| 829 M | -0,2% | 11,86% | -0,5% | - | -6.61x | |
| 437 M | -36,42% | -29,57% | -7,45% | -7,74% | 6.67x | |
| 88,04 M | -891,6% | -695,44% | - | -55,55% | 0.05x | |
| 113 M | -310,18% | -226% | - | - | - | |
| 463 M | 21,89% | 22,29% | 25,37% | 11,13% | 2.45x | |
| Moyenne | 1,72 Md | -134,87% | -124,75% | -12,23% | 2,89% | 0,63x | |
| Moyenne pondérée par Capi. | 3,07 Md | -39,28% | -29,43% | -9,44% | 9,91% | -0,17x |
- Bourse
- Actions
- Action ACRS
- Secteur Aclaris Therapeutics, Inc.
- Comparaisons Financières
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
